Ryan Cohlhepp
President and COO at Bicara Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Bicara Therapeutics Inc., 1 year.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Bicara Therapeutics Inc. | Option exercise | +17,500 | $3.79 | $66,325 |
| Sep 8, 2026 | Bicara Therapeutics Inc. | Open-market sale | −14,058 | $22.77 | $320,101 |
| Sep 8, 2026 | Bicara Therapeutics Inc. | Open-market sale | −3,442 | $23.43 | $80,646 |
| Aug 10, 2026 | Bicara Therapeutics Inc. | Option exercise | +18,750 | $3.79 | $71,063 |
| Aug 10, 2026 | Bicara Therapeutics Inc. | Open-market sale | −18,750 | $27.98 | $524,625 |
| Jul 9, 2026 | Bicara Therapeutics Inc. | Open-market sale | −536 | $29.00 | $15,544 |
| Jul 8, 2026 | Bicara Therapeutics Inc. | Option exercise | +18,750 | $3.79 | $71,063 |
| Jul 8, 2026 | Bicara Therapeutics Inc. | Open-market sale | −22,833 | $28.76 | $656,677 |
| Jul 8, 2026 | Bicara Therapeutics Inc. | Open-market sale | −4,306 | $29.80 | $128,319 |
| Jul 8, 2026 | Bicara Therapeutics Inc. | Open-market sale | −1,075 | $30.35 | $32,626 |
| May 15, 2026 | Bicara Therapeutics Inc. | Option exercise | +8,000 | $3.79 | $30,320 |
| May 15, 2026 | Bicara Therapeutics Inc. | Open-market sale | −8,000 | $20.29 | $162,320 |
| May 15, 2026 | Bicara Therapeutics Inc. | Open-market sale | −4,500 | $20.29 | $91,305 |
| Apr 15, 2026 | Bicara Therapeutics Inc. | Option exercise | +8,000 | $3.79 | $30,320 |
| Apr 15, 2026 | Bicara Therapeutics Inc. | Open-market sale | −8,000 | $23.01 | $184,080 |
Questions about Ryan Cohlhepp
What boards is Ryan Cohlhepp on?
Ryan Cohlhepp sits on the board of Bicara Therapeutics Inc.
What company is Ryan Cohlhepp the CEO of?
Ryan Cohlhepp is President, COO & Interim CEO of Bicara Therapeutics Inc.
How long has Ryan Cohlhepp served on boards?
Our records show at least 1 year of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.